Revance Therapeutics (RVNC) SEC News May 15, 2025, 20:34 UTC New Form SCHEDULE 13G/A - Revance Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001076809-25-000060 Size: 8 KB Full text
There are no comments here yet...